Article PDF
Avoid common mistakes on your manuscript.
References
Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 2004; 8: 636–647.
Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis 1999; 3: S231–S279.
Jawahar MS. Current trends in chemotherapy of tuberculosis. Indian J Medical Res 2004; 120: 398–417
Mwandumba HC, Squire SB. Fully intermittent dosing with drugs for treating tuberculosis in adults. Cochrane Database Syst Rev 2001; 4: CD000970.
Menon P, Lodha R, Sivanandan S, Kabra SK. Intermittent or daily short course chemotherapy for tuberculosis in children: meta-analysis of randomized clinical trials. Indian Pediatr 2010; 47: 67–73.
Gurumurthy P, Ramachandran G, Hemanth Kumar AK, Rajasekaran S, Padmapriyadarsini C, et al. Malabsorption of rifampicin and isoniazid in HIVinfected patients with and without tuberculosis. Clin Infect Dis 2004; 38: 230–233.
Schaaf HS, Parkin DP, Seifart HI, Werely CJ, Hesseling PB, van Helden PD, et al. Isoniazid pharmacokinetics in children treated for respiratory tuberculosis. Arch Dis Child 2005; 90:614–618.
Schaaf HS, Willemse M, Cilliers K, Labadarios D, Maritz JS, Hussey GD, et al. Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of tuberculosis. BMC Med 2009; 7:19–29.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Swaminathan, S. Evidence-based treatment of tuberculosis for children: The unfinished agenda. Indian Pediatr 47, 39–40 (2010). https://doi.org/10.1007/s13312-010-0003-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-010-0003-8